Rationale: SPEG (Striated muscle preferentially expressed protein kinase) has 2 kinase-domains and is critical for cardiac development and function. However, it is not clear how these 2 kinase-domains function to maintain cardiac performance. Thr484Ala mutant protein also slowed sarcoplasmic reticulum calcium reuptake in neonatal rat cardiomyocytes. In contrast, domain mapping and phosphorylation analysis revealed that the first kinase-domain of SPEG interacted and phosphorylated its recently identified substrate JPH2 (junctophilin-2). An inducible heart-specific Speg knockout mouse model was generated to further study this SPEG-SERCA2a signal nexus in vivo. Inducible deletion of Speg decreased SERCA2a-Thr 484 phosphorylation and its oligomerization in the heart. Importantly, inducible deletion of Speg inhibited SERCA2a calcium-transporting activity and impaired calcium reuptake into the sarcoplasmic reticulum in cardiomyocytes, which preceded morphological and functional alterations of the heart and eventually led to heart failure in adult mice. 
C alcium entry into and release from the sarcoplasmic reticulum (SR) are pivotal processes during excitationcontraction coupling to control the contraction and relaxation cycle of cardiac muscle, whose dysregulation causes cardiac dysfunction and is directly linked to cardiomyopathy and heart failure. 1 Restoration of cardiac calcium homeostasis is an attractive strategy to treat heart disease associated with calcium dysregulation, which requires a comprehensive understanding of how this process is regulated. 6 SERCA2a can be phosphorylated on Ser 38 by SR-associated CaMK (Ca 2+ /calmodulin-dependent protein kinase), 7 whose physiological relevance in regulation of calcium reuptake is still to be determined. There is also evidence that SERCA2a forms functional oligomers in cardiac muscle, [8] [9] [10] analogous to the functional dimeric unit of SERCA1 in skeletal muscle. 11 SPEG (striated muscle preferentially expressed protein kinase) is a member of the MLCK (myosin light chain kinase) subgroup of CaMK Ser/Thr (serine/threonine) protein kinase family. 12 It is mainly found in the skeletal muscle and heart and has 2 Ser/Thr kinase (SK) domains in its C-terminal region, referred to as SK1 and SK2. 12 Its deletion in mice impairs cytoskeleton function in cardiomyocytes in the developing heart and causes dilated cardiomyopathy in mouse embryos. Consequently, mice with whole-body deletion of SPEG die neonatally probably because of cardiac dilatation during heart development. 13 Neonatal death in these mice can be rescued by administration of cardiac progenitor cells.
14 Moreover, cardiac-specific deletion of SPEG in adult mice also caused dilated cardiomyopathy and resulted in heart failure. 15 Human patients carrying homozygous or compound-heterozygous SPEG mutations also develop dilated cardiomyopathy. 16 Besides its effects in the heart, deficiency of SPEG can also cause centronuclear myopathy in skeletal muscle in mice as well as in human. 16 These studies demonstrate a critical role of SPEG in striated muscle and also heighten the needs to elucidate the underlying mechanisms. Being a member of the MLCK subgroup, the SK1 of SPEG exhibits higher similarity with other kinases within this subgroup than does the SK2. 12 So far, it remains unclear how these 2 kinase domains of SPEG function to maintain cardiac performance.
In this study, we identified SERCA2a as a protein that interacted with the SK2 of SPEG in the heart and demonstrated a critical role of the SK2 of SPEG in regulating calcium reuptake into the SR through phosphorylation and oligomerization of SERCA2a.
Methods
The authors declare that all supporting data are available within the article and its Online Data Supplement files.
Materials
Protein G-Sepharose was purchased from GE Healthcare (Little Chalfont, Buckinghamshire, United Kingdom). Precast NuPAGE Bis-Tris gels and the crosslinker dithiobis[succinimidyl propionate] were from Thermo Fisher Scientific (Waltham, MA). All other chemicals were from Sigma-Aldrich (Shanghai, China) or Sangon Biotech (Shanghai, China).
Antibodies
The rabbit antibody against SPEG (Catalog No. 12472-RP02) was from Sino Biologicals (Beijing, China). 
Novelty and Significance
What Is Known?
• Calcium reuptake into the sarcoplasmic reticulum (SR) through SERCA2a (sarcoplasmic/endoplasmic reticulum calcium ATPase 2a) is a pivotal process for heart function. SERCA2a dysregulation is directly linked to cardiomyopathy and heart failure.
• SPEG (Striated muscle preferentially expressed protein kinase), which has 2 kinase domains, regulates cardiac development and function.
• The molecular mechanisms how SPEG maintains cardiac performance remain largely unknown.
What New Information Does This Article Contribute?
• The second kinase domain of SPEG interacts with SERCA2a and phosphorylates Thr 484 of SERCA2a.
• Thr 484 phosphorylation promotes oligomerization of SERCA2a and stimulates its activity for calcium reuptake into the SR.
• Knockout of SPEG decreases SERCA2a-Thr 484 phosphorylation and prolongs calcium reuptake by SR, which leads to the development of heart failure.
SPEG deficiency causes dilated cardiomyopathy and heart failure in human patients, as well as in mouse models, heightening the needs to elucidate the underlying mechanisms. In this study, we identified SERCA2a as a protein phosphorylation substrate for the second kinase domain of SPEG. SPEG-mediated phosphorylation of SERCA2a promotes its oligomerization and increases its activity for calcium reuptake into the SR. SPEG deficiency in cardiac myocytes decreases SERCA2a phosphorylation and delays calcium reuptake into the SR, which leads to the development of heart failure. These findings suggest that SPEG may serve as a new target to modulate SERCA2a activity for the treatment of cardiac conditions associated with impaired calcium homeostasis. 
Molecular Biology
The mouse SPEG cDNA or human SERCA2a cDNA were cloned into the vectors pcDNA5-FRT/TO-GFP or pcDNA5-FRT/TO-HA or pcDNA5-FRT/TO-Flag for expression in mammalian cells or cloned into the pGEX6P vector for protein expression in Escherichia coli. Fragmentation and point mutation of SPEG or SERCA2a were performed using standard procedures. The sequence contexts of mutated sites on SERCA2a are LMKKEFtLEFSRD 17 and αMHC-Cre 18 mice on a C57Bl/6J background, were bought from the Nanjing Biomedical Research Institute of Nanjing University, and mated with the Speg f/f mice to obtain cardiac-specific Speg inducible knockout mice and cardiac-specific Speg knockout mice, respectively.
Mouse Breeding, Husbandry, and Tamoxifen Induction
All mouse procedures used in this study were approved by the Ethics Committee at Model Animal Research Center of Nanjing University. Minimal numbers of animals were used in the study, which could still allow for generation of statistically meaningful results. Mice were maintained under specific pathogen-free conditions with a light/dark cycle of 12 hours.
As for inducible cardiac-specific knockout mice, Speg f/f X Speg f/f / Myh6-MCM mating was set up to generate Speg f/f (control mice) and Speg f/f /Myh6-MCM (cardiac-specific Speg inducible knockout mice). As for cardiac-specific knockout mice, Speg f/f X Speg f/f /αMHC-Cre mating was set up to generate Speg f/f (control mice) and Speg f/ f /αMHC-Cre (cardiac-specific Speg knockout mice). The Speg flox allele was genotyped via polymerase chain reaction (PCR) using the following primers: 5ʹ-CTCAGTCATAGCAGCATCAC-3ʹ and 5ʹ-ATCCAAAGCCAGGTTTACCCC-3ʹ. The Cre locus was genotyped via PCR using the following primers: 5ʹ-AATGCTTCTGTCCGTTTGC-3ʹ and 5ʹ-ACCAGAGTCATCCTTAGCG-3ʹ. For tamoxifen induction, mice were intraperitoneally administered with 20 mg/kg per day tamoxifen for 5 consecutive days.
Tissue Lysis and Measurement of Protein Concentration
After harvest, mouse tissues were snap-frozen in liquid nitrogen and homogenized in lysis buffer using a Polytron homogenizer (Kinematica, Luzern, Switzerland) as previously described. 19 Homogenates were further lysed on ice for 30 minutes, and tissue debris was removed through centrifugation. Protein concentrations were determined using Bradford reagent (Thermo Scientific).
Immunoprecipitation and Immunoblotting
Immunoprecipitation was performed as previously described. 19 Briefly, tissue or cell lysates were mixed with the antibody-coupled protein G-Sepharose or GFP-binder (ChromoTek GmbH, Planegg-Martinsried, Germany) and incubated overnight at 4°C. Thereafter, nonspecific binding proteins were removed through washing, and immunoprecipitates were eluted off from the resins in SDS sample buffer.
For SERCA2a dimerization assay via immunoblotting, cell or tissue lysates were denatured in SDS sample buffer without reducing agents at room temperature for 15 minutes. In all the other immunoblotting assays, samples were denatured in SDS sample buffer containing reducing agents at 95°C for 15 minutes. After separation via SDS-PAGE, lysates or immunoprecipitates were immunoblotted onto nitrocellulose membranes. Membranes were then sequentially incubated with primary antibodies and horseradish-peroxidaseconjugated secondary antibodies. After incubation with enhanced chemiluminescence substrates (GE Healthcare, United Kingdom), chemiluminescence signals were recorded using a gel documentation system (Syngene, United Kingdom). Images of immunoblots were quantified using ImageJ. When protein phosphorylation was quantified, signals for phosphorylated proteins were normalized with corresponding total proteins. When total proteins were quantified, their signals were normalized with internal loading controls.
Mass Spectrometry
Immunoprecipitated proteins were electrophoretically separated in precast NuPAGE Bis-Tris gels. After stained with Coomassie dye, protein bands were excised and digested with trypsin. The resultant peptides were analyzed by liquid chromatography-mass spectrometry on an LTQOrbitrap (Thermo Finnigan) mass spectrometer coupled to a Dionex 3000 nano-liquid chromatography system as described previously.
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Generation of Site-Specific pThr 484 -SERCA2a Antibody
The antibody that recognizes phosphorylated Thr 484 site in SERCA2a was raised in rabbit against the following synthetic phosphopeptide: CLMKKEFpTLEFSRD (Cys for coupling, plus residues 478 to 490 of human SERCA2a, where pT represents phosphorylated Thr 484 ). Immunization of rabbits using the phosphopeptide was performed at ChinaPeptides (Shanghai, China), and the site-specific pThr 484 -SERCA2a antibody was purified on CH-Sepharose coupled to the same peptide.
In Vitro Phosphorylation
The recombinant GST-SPEG-SK2 and GST-SPEG-SK2 D3098A proteins were expressed in E coli and purified using glutathione-Sepharose 4B (GE-Healthcare). The purified GST-SPEG-SK2 wild-type and mutant proteins were used to phosphorylate the Thr 484 peptide (CLMKKEFtLEFSRD, Thr 484 shown in lower-case bold) in vitro at 30°C for 30 minutes as previously described.
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Echocardiography
Echo was performed in a double-blinded manner on mice anaesthetized with gaseous isoflurane using a Vevo 770 high resolution in vivo micro-imaging system (VisualSonics, Inc) with a 30 MHz RMV-707B ultrasonic probe as previously described. 22 M-mode pictures were collected via the ultrasonic probe that was positioned with a 90° angle between the probe and the heart. Left ventricle (LV) anterior wall, LV posterior wall, LV internal dimension, and LV volume of systole and diastole were determined on the M-mode tracing in a double-blinded manner and averaged from 6 cardiac cycles. 
Primary Cardiomyocyte Isolation
Primary mouse cardiomyocytes were isolated using a collagenasebased method and cultured as previously described. 23 Briefly, anesthetized mice were administered with heparin (5 U per gram of body weight). Mice were terminated 5 minutes after heparin administration, and the heart was rapidly removed and mounted onto a catheter. Afterwards, the heart was perfused with a collagenase solution (1 mg/mL) using a Langendorff system (ADInstruments). After digestion, the heart tissue was dissociated, and the cell suspension was filtered through a 100 μm cell strainer. The cardiomyocytes were then suspended and precipitated in Krebs-Henseleit buffer B containing 5 mmol/L taurine and 10 mmol/L 2,3-butanedione monoximine with Ca 2+ (0.1 mmol/L for the first round, 0.2 mmol/L for the second round, and 0.6 mmol/L for the third round). Isolated primary cardiomyocytes were resuspended in Hanks buffer containing 1 mmol/L MgCl 2 , 1 mmol/L CaCl 2 , and 2% (w/v) BSA.
Primary neonatal rat cardiomyocytes were isolated and cultured as previously described. 24 Briefly, ventricles of hearts from neonatal rats (postnatal day 0-3) were minced into ≈1 mm cubes and digested with 0.25% trypsin at 4°C overnight. On the next day, the trypsintreated cardiac tissues were further digested with collagenase (1 mg/mL) at 37°C for 15 minutes, and the resultant cell suspensions were seeded into DMEM containing 10% (v/v) fetal bovine serum for 1 hour. Afterwards, fibroblasts were removed, and cardiomyocytes were reseeded into fresh DMEM plus 10% (v/v) fetal bovine serum. Transfection of plasmids or siRNA was performed with Lipofectamine 3000 reagent (Thermo Fisher Scientific). The siRNA for rat Speg was as follows, 5ʹ-GCUCGAAGCUGGAGAAGAU-3ʹ.
Calcium Imaging
Cardiomyocytes were loaded with 5 μmol/L Fluo-4-AM (Thermo Fisher Scientific) and imaged using a Zeiss LSM510 confocal microscope. For calcium sparks, calcium-loaded cells were directly imaged using the confocal microscope. For calcium transient assay in primary mouse cardiomyocytes, calcium-loaded cells were subjected to field stimulation using a GRASS S48 stimulator (frequency 0.5 Hz, duration 60 ms, decay 40 ms, voltage 80 V, repeat) when imaged with the confocal microscope. For calcium transient assay in neonatal rat cardiomyocytes, field stimulation was also performed using a GRASS S48 stimulator (frequency 1 Hz, duration 4 ms, decay 20 ms, voltage 40 V, repeat). For SR calcium load assay, calciumloaded cells were subjected to field stimulation and then treated with 10 mmol/L caffeine. Line-scan images were taken with the LSM510 confocal microscope and analyzed using IDL5.5 (Harris Geospatial Solutions) as previously described. 25 The decay time (τ) was measured from the peak of calcium transients to 63% from the peak to the basal level in the fading phase.
Cell Culture, Transfection, and Lysis
Human embryonic kidney HEK293 cells were bought from the Cell Resource Center, Chinese Academy of Medical Sciences and Peking Union Medical College (China), and were regularly tested for mycoplasma contamination. Cells were cultured in DMEM medium containing 10% (v/v) fetal bovine serum and transfected with plasmid DNA using Lipofectamine 3000 reagent (Thermo Fisher Scientific). Two days after transfection, cells were lysed as previously described.
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Calcium Transient Assay in HEK293 Cells
HEK293 cells were transfected to express SERCA2a together with SPEG or an empty vector and further cultured for 2 days. After incubated with 5 μmol/L Fluo-4-AM, cells were imaged using an Olympus confocal microscope in a frame scan mode for ≈30 seconds. Cells were then stimulated with 200 μmol/L carbamylcholine or 100 μmol/L ATP, and images were continuously taken for ≈270 seconds.
Microsome Isolation and Ca
2+ -ATPase Activity Assay
Microsomes containing crude ER membrane vesicles were isolated as previously described. 26, 27 The ATPase activity of SERCA2 was determined via measurement of inorganic phosphate resulted from ATP hydrolysis as previously described. 27 Briefly, isolated microsomes (50 μg protein) were incubated with an assay buffer containing 100 mmol/L KCl, 10 mmol/L HEPES (pH 7.4), 5 mmol/L MgCl 2 , 100 μmol/L CaCl 2 , 1.5 mmol/L ATP, 2 μmol/L A23187, and 5 mmol/L sodium azide in the absence (total activity) or presence of 5 μmol/L thapsigargin (activity of thapsigargin-insensitive calcium pumps) at 30°C for 30 minutes. The reaction was stopped by addition of ice-cold 10% trichloroacetic acid. The amounts of inorganic phosphate were determined using a colorimetric method. 28 The thapsigargin-sensitive 
Ca
2+ Uptake Measurement
Ca 2+ uptake was measured using a Fura-2 based method as previously described. 29 Briefly, microsomes were incubated in assay buffer (100 mmol/L KCl, 10 mmol/L HEPES-KOH (pH 7.4), 10 mmol/L oxalate, 5 mmol/L MgCl 2 , 10 μmol/L ruthenium red, and 2 μmol/L Fura-2 free acid). The uptake reaction was initiated by addition of 5 mmol/L ATP and 2 μmol/L Ca 2+ . The fluorescence ratio (excitation at 340 and 380 nmol/L) was recorded at 510 nmol/L emission using a fluorescence microplate reader (BioTek). The rate of Ca 2+ uptake into microsomes was calculated by measuring the linear portion of the slope after addition of Ca 2+ as previously described.
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Histology
After termination of mice, hearts were fixed in 4% PFA overnight at 4°C, and histology was performed as previously described. 22 Hearts were embedded in paraffin wax and sectioned into 5 μm-thick slices using a Leica RM2016 microtome, and heart sections were stained with Hematoxylin-Eosin. Pictures were taken using an Olympus BX53F microscope.
Immunofluorescence Staining and Imaging
Immunofluorescence staining was performed as previously described. 19 Heart sections were permeabilized and sequentially incubated with primary antibodies and fluorophore-conjugated secondary antibodies. Specificity of immunofluorescence staining was verified via using rabbit IgG as a negative control. Pictures were taken with a Leica confocal microscope, and representative images are shown.
Fluorescence Resonance Energy Transfer Assay
HEK293 cells were transfected with ECFP-SERCA2a and EYFPSERCA2a plasmids in a 1:1 molar ratio. Two days after transfection, cells were subjected to fluorescence resonance energy transfer (FRET) assays using a Leica SP5 confocal microscope, as described in the Leica FRET Sensitized Emission application manual. Cells coexpressing ECFP-SERCA2a and EYFP-SERCA2a were selected for FRET assay. The FRET efficiency was calculated using the following formula: FRET efficiency (%) =(FRET signal-β×Donor Signalγ×Acceptor signal)/(Acceptor signal), where β is obtained with donor only specimen and calculated as β = Signal indirectAcceptor /Signal Donor , and γ is obtained with acceptor only specimen and calculated as γ =Signal IndirectAcceptor /Signal DirectAcceptor .
RNA Isolation and Quantitative PCR
Extraction of total RNA was performed using the TRIzol Reagent (Life Technologies), and reverse-transcription was performed using a PrimeScript RT reagent kit (DRR047A, TaKaRa). Quantitative PCR was performed to determine expression levels of target genes using an Applied Biosystems StepOnePlus Real-Time PCR system (Life Technologies). The primers used for quantitative PCR were listed in Online Table I .
Statistical Analysis
Data were checked for normal distribution via D'Agostino-Pearson test using Prism software (GraphPad, San Diego, CA). Comparisons were performed via t test for 2 groups, or via 1-way or 2-way ANOVA with Tukey method for post-test for multiple groups as indicated in the figure legends using Prism software (GraphPad, San Diego, CA). Differences were considered statistically significant at P<0.05.
Results
SPEG Interacted With SERCA2a and Regulated Calcium Reuptake Into Endoplasmic Reticulum
We first examined Speg expression in mouse models of heart failure induced by isoproterenol or transaortic constriction and found its mRNA levels were significantly decreased in hearts of both models (Online Figure IA and IB) . To gain insights how SPEG functions, we overexpressed GFP-SPEG in HEK293 cells and immunoprecipitated it from cell lysates to identify potential interactors for SPEG. Proteins in the immunoprecipitates were identified via mass spectrometry and subjected to gene ontology term analysis. Proteins possessing calcium-transporting ATPase activity were enriched in the immunoprecipitates, which include SERCA2 (also known as AT2A2), AT2B1, AT2B3, and AT2B4 ( Figure 1A ; Online Table II and Online Figure IIA) . Because SPEG is critical in the heart where SERCA2a plays a key role in regulating calcium homeostasis, 3 we then focused on a possible relationship between them. Both proteins localize along the diads where transverse tubules that conduct electrical impulses pair with sarcoplasmic reticular cisternae that mediate Ca 2+ exchange to control excitation-contraction coupling in cardiomyocytes (Online Figure IIB and IIC) . Endogenous SERCA2a could be detected in immunoprecipitates of endogenous SPEG from heart lysates in which proteins were chemically cross-linked with dithiobis[succinimidyl propionate] ( Figure 1B) . In a reciprocal coimmunoprecipitation experiment, endogenous SPEG was also found in immunoprecipitates of endogenous SERCA2a from heart lysates ( Figure 1C ). Furthermore, GFP-SPEG could interact with HA-SERCA2a when they were coexpressed in HEK293 cells ( Figure 1D ). GFP-SPEG did not affect translation and turnover of HA-SERCA2a in HEK293 cells (Online Figure IIIA through IIID) . Importantly, the full duration at half maximum (FDHM) and time constant τ of Ca 2+ transients that are 2 measures for SERCA2a activity were both significantly decreased while the amplitude of Ca 2+ transients remained normal when SERCA2a was coexpressed with SPEG in cells as compared with its coexpression with GFP ( Figure 1E and 1F) . These data suggest that expression of SPEG accelerated calcium reuptake into endoplasmic reticulum via SERCA2a in these cells.
SK2 of SPEG Interacted With SERCA2a and Led to its Phosphorylation
We next investigated how SPEG regulates SERCA2a. SPEG has 2 kinase domains, SK1 and SK2, at its C-terminal part (Figure 2A) . 12 Interaction domain mapping revealed that a fragment SPEG T2946-end containing SK2 interacted with SERCA2a when coexpressed in cells ( Figure 2B and 2C) . Furthermore, we found that coexpression of SPEG could increase phosphorylation of SERCA2a in HEK293 cells that could be detected with a phospho-Ser/Thr specific antibody ( Figure 2D and 2E). Asp 1746 and Asp 3098 are predicted to be key residues for kinase activities of SK1 and SK2 domains Figure 1 . Identification of SERCA2a (sarcoplasmic/endoplasmic reticulum calcium ATPase 2a) as an SPEG (striated muscle preferentially expressed protein kinase)-interacting protein. A, GFP (green fluorescent protein)-SPEG fusion protein was expressed in HEK293 cells and immunoprecipitated from cell lysates using the GFP-binder. Mock immunoprecipitation was performed using HEK293 cell lysates. The protein bands shown in brackets were excised, digested with trypsin, and identified via mass spectrometry. B, Endogenous SPEG was immunoprecipitated from heart lysates that were cross-linked using a cross-linker dithiobis[succinimidyl propionate] (DSP), and endogenous SERCA2a was detected in the immunoprecipitates using the goat anti-SERCA2a antibody. C, Endogenous SERCA2a was immunoprecipitated using the mouse anti-SERCA2a antibody from heart lysates that were cross-linked using a cross-linker DSP, and endogenous SPEG was detected in the immunoprecipitates. D, Flag-SERCA2a was coexpressed with GFP-SPEG or free GFP in HEK293 cells. Coimmunoprecipitated Flag-SERCA2a was detected in the immunoprecipitates of GFP-SPEG or free GFP via western blot. E and F, Calcium transients in HEK293 cells expressing mCherry-SERCA2a together with HA (hemagglutinin)-SPEG or empty vector. Calcium transients were recorded using a confocal microscopy in cells that were stimulated with carbamylcholine. Full duration at half maximum (FDHM) (E) and time constant τ (F) of calcium transients were quantified. n=86-89. The data are given as the mean±SEM. *** indicates P<0.001.
of SPEG, respectively. 12 Interestingly, mutation of Asp 3098 to alanine abolished the ability of SPEG to phosphorylate SERCA2a while mutation of Asp 1746 to glycine had no such effect, showing that SK2 of SPEG is responsible for phosphorylation of SERCA2a ( Figure 2F ). The FDHM and τ of Ca 2+ transients were significantly larger when SERCA2a was coexpressed with SPEG Asp3098Ala than with SPEG wild-type protein ( Figure 2G and 2H) , suggesting that SPEG-mediated phosphorylation of SERCA2a accelerated calcium reuptake into endoplasmic reticulum. Importantly, expression of SPEG-SK2 in neonatal rat cardiomyocytes significantly decreased the FDHM and τ of Ca 2+ transients and increased their amplitudes ( Figure 2I ). In contrast, expression of SPEG-SK1 increased the FDHM and τ of Ca 2+ transients in neonatal rat cardiomyocytes and depressed their amplitudes (Online Figure IVA) . In the agreement, SPEG-SK1 decreased expression of full-length SPEG in HEK293 cells (Online Figure IVB  and IVC) . Therefore, it is likely that expression of SPEG-SK1 delayed Ca 2+ reuptake through interference with endogenous SPEG expression. Together, these data show that the SK2 of 3098 are predicted to be key residues for kinase activities of SK1 and SK2 domains of SPEG, respectively. B and C, GFP (green fluorescent protein)-tagged SPEG fragments were coexpressed with HA (hemagglutinin)-SERCA2a in HEK293 cells. GFP-tagged SPEG fragments were immunoprecipitated from cell lysates using the GFP-binder, and HA-SERCA2a was detected in the immunoprecipitates using the HA antibody via Western blot. D and E, Phosphorylation of SERCA2a by SPEG. HA-SERCA2a was coexpressed with GFP-SPEG or free GFP in HEK293 cells, and immunoprecipitated from cell lysates using an HA antibody. Phosphorylation of SERCA2a was detected on the immunoprecipitated HA-SERCA2a using an antibody recognizing phosphorylated Ser/Thr residues (pSer/Thr). E, Quantitation of phosphorylation of HA-SERCA2a using the blot shown in D. F, Flag-SERCA2a was coexpressed with GFP-SPEG WT or mutant proteins in HEK293 cells. After immunoprecipitated from cell lysates, phosphorylation of Flag-SERCA2a was detected using the pSer/Thr antibody. SPEG interacted with SERCA2a and increased its activity via protein phosphorylation.
As recently reported, 15 SPEG could interact with JPH2 (junctophilin-2) when they were coexpressed in cells (Online Figure VA) . Interaction domain mapping showed that a fragment SPEG T1563-S2583 containing SK1 but not a fragment SPEG D2584-end containing SK2 interacted with SERCA2a when coexpressed in cells (Online Figure VB) . In contrast to SERCA2a phosphorylation, the SPEG Asp1746Gly mutation but not SPEG Asp3098Ala mutation blunted SPEG-mediated phosphorylation of JPH2 (Online Figure VC) . These data demonstrate that the SK1 of SPEG interacted with JPH2 and led to its phosphorylation.
SPEG Could Promote Oligomerization of SERCA2a in a Manner Dependent on SPEG-Mediated Phosphorylation
Visualizing blots of SDS-gels revealed that coexpression with SPEG increased the oligomerization of SERCA2a ( Figure 3A) , which has been proposed to enhance Ca 2+ -transporting activity of SERCA2a but not its ATPase activity. [8] [9] [10] This effect was further confirmed via a FRET-based assay in which CFPSERCA2a and YFP-SERCA2a were coexpressed with HA-SPEG or empty vector ( Figure 3B and 3C) , by the enhanced coimmunoprecipitation of HA-SERCA2a and Flag-SERCA2a from lysates of cells cotransfected with GFP-SPEG as compared with cotransfection with GFP ( Figure 3D ).
We then examined whether this SPEG-induced oligomerization of SERCA2a depended on phosphorylation of the latter. Interestingly, the SPEG Asp3098Ala mutant protein failed to increase oligomerization of SERCA2a while mutation of Asp 1746 to glycine did not affect the ability of SPEG to promote SERCA2a oligomerization in both immunoblotting and FRET assays ( Figure 3E through 3G) , suggesting a dependence of SERCA2a oligomerization on its phosphorylation. We mutated possible phosphorylation sites (www.phosphosite. org) in the cytoplasmic domain of SERCA2a to nonphosphorylatable alanine and assayed its oligomerization status. Through this strategy, Thr 484 was identified as a key residue for SERCA2a oligomerization ( Figure 3H) . A Thr 484 Ala substitution decreased SPEG-dependent intermolecular interaction of SERCA2a in all 3 assays, including immunoblotting, FRET, and coimmunoprecipitation assays ( Figure 3H and 3K) . Interestingly, the Thr 484 residue is located in a β-sheet on the nucleotide (N) domain of SERCA2a, and positioned directly beneath a loop region that is involved in the intermolecular interaction of SERCA2a monomers in a molecular docking model (Online Figure VIA) . 10 SPEG could increase intermolecular interaction of the N-domain containing cytosolic region of SERCA2a, which was decreased by the Thr 484 Ala substitution (Online Figure VIB) .
Thr 484 Phosphorylation of SERCA2a by SPEG Increased Its Activity
Next, we examined whether SPEG could indeed phosphorylate Thr 484 of SERCA2a and whether this phosphorylation regulated SERCA2a activity. Eleven phosphorylation sites, including pThr 484 on SERCA2a, were also identified through mass spectrometry when the Ca 2+ pump was coexpressed with SPEG in HEK293 cells ( Figure 4A ). The Thr 484 Ala mutation prevented SPEG-mediated Ser/Thr phosphorylation of SERCA2a (Online Figure VIIA) . We raised a site-specific antibody recognizing phosphorylated Thr 484 on SERCA2a (Online Figure VIII) , and further confirmed that coexpression of SPEG could increase Thr 484 phosphorylation of SERCA2a in HEK293 cells, which was blunted by the Thr 484 Ala mutation ( Figure 4B ). In an in vitro phosphorylation assay, the SPEG-SK2 wild-type protein but not the SPEG-SK2 Asp3098Ala mutant protein was capable of phosphorylating a Thr 484 containing peptide (CLMKKEFtLEFSRD, Thr 484 shown in lower-case bold) ( Figure 4C ). Thr 484 phosphorylation of SERCA2a was substantially decreased when Speg was knocked down in neonatal rat cardiomyocytes as well as in H9C2 cardiomyocytes (Figure 4D Ala substitution did not affect SERCA2a ATPase activity ( Figure 4I ). Moreover, expression of SERCA2a
Thr484Ala decreased the peaks of Ca 2+ transients in neonatal rat cardiomyocytes as compared with expression of the wild-type SERCA2a ( Figure 4G ). Taken together, these data show that SPEG phosphorylates Thr 484 of SERCA2a to promote its oligomerization and increase its Ca 2+ -transporting activity without affecting its ATPase activity.
Cardiac-Specific Deletion of SPEG Decreased Thr
484
Phosphorylation of SERCA2a and Caused Dilated Cardiomyopathy in Mice
We next sought to investigate regulation and function of this SPEG-SERCA2a signal nexus in vivo. SPEG protein did not change in the heart from E18.5 to postnatal day-4 but increased from postnatal day-4 to day-7 (Online Figure  IXA) . We mated a Speg f/f mouse with a αMHC-Cre mouse 18 to specifically delete Speg in the heart after birth. SPEG protein levels were normal in neonates of the Speg f/f /αMHC-Cre mice (1-day-old) and decreased to ≈10% of control levels in the heart but not in skeletal muscle at the age of 1 month ( Figure 5A ; Online Figure IXB) . Importantly, SERCA2a expression was not altered while its Thr 484 phosphorylation was substantially decreased in the heart of 1-month-old Speg f/ f /αMHC-Cre mice ( Figure 5B ), suggesting that SPEG could phosphorylate SERCA2a in vivo. The Speg f/f /αMHC-Cre mice had enlarged hearts with dilation phenotype, and their heart-to-body weight ratios were increased from 1 month after birth ( Figure 5C ; Online Figure IXC and IXD) . Heart function was impaired in the Speg f/f /αMHC-Cre mice as early as 2-week-old as evidenced by lower ejection fraction and fraction shortening (Figure 5D and 5E; Online Figure IXE and IXF). Substantial cardiac remodeling occurred in the heart of Speg f/f /αMHC-Cre mice (2-month-old; Online Figure  IXG) . As a consequence of dilated cardiomyopathy, the Speg f/ f /αMHC-Cre mice died within 5 months after birth (Online Figure IXH) . Because the αMHC-Cre starts to express in the heart from postnatal day 2 when cardiomyocytes still undergo proliferation and maturation, 31 it is possible that deletion of Speg using the αMHC-Cre still interferes with development of cardiomyocytes, which might contribute to the early death within the first few weeks after birth.
Heart failure can interfere with calcium homeostasis in cardiomyocytes. 32 Cardiac dysfunction occurred in the Speg f/f /αMHC-Cre mice as early as 2-week-old, which did not allow us to study calcium reuptake in cardiomyocytes from these knockout mice when their cardiac function was normal. To find such a time window, we mated a Speg f/f mouse with a Myh6-MCM mouse 17 to enable inducible deletion of Speg in the adult heart. Before tamoxifen induction, the resultant Speg f/f /Myh6-MCM mice displayed no overt phenotype and had normal SPEG expression in the heart. After tamoxifen treatment, the levels of SPEG protein in the heart of Speg f/f / Myh6-MCM mice gradually diminished until <10% of control levels could be detected by 4 weeks post-tamoxifen induction ( Figure 6A ). In contrast, tamoxifen did not affect SPEG expression in skeletal muscle (Online Figure XA) . The heart of Speg f/f /Myh6-MCM mice displayed normal gross morphology by 4 weeks post-tamoxifen induction but became dilated with increased ratios of heart-to-body weight by 8 weeks after tamoxifen treatment ( Figure 6B ; Online Figure XB stage to examine impacts of SPEG deficiency on SERCA2a phosphorylation. SERCA2a expression, and expression and phosphorylation of the SERCA2a regulator PLB, were all normal in the heart of the Speg f/f /Myh6-MCM mice at 4 weeks after tamoxifen administration (Online Figure XIIA through  XIIE) . Importantly, Thr 484 phosphorylation and oligomerization of SERCA2a were both significantly decreased in the heart of the Speg f/f /Myh6-MCM mice at 4 weeks after tamoxifen induction (Figure 7A through 7D) . Together, these data demonstrate that SPEG could phosphorylate SERCA2a in vivo.
Calcium Reuptake Into the SR Was Delayed in SPEG Knockout Cardiomyocytes
We next investigated how the disruption of this SPEGSERCA2a signal nexus affected calcium homeostasis in the heart and primary cardiomyocytes. Rcan1.4 is a target of the calcineurin-NAFT pathway, and its expression is positively correlated with cytosolic Ca Figure 8A and 8B) . In contrast, the FDHM and τ were both significantly increased in the SPEG knockout cardiomyocytes at 4 weeks after induction ( Figure 8A and 8B) , suggesting that calcium reuptake into the SR through SERCA2a was delayed in these cells. At 6 and 8 weeks after induction, Ca 2+ -transients were significantly depressed in SPEG knockout cardiomyocytes ( Figure 8C ; Online Figure XIVA) . Again, the FDHM and τ were both significantly augmented in the SPEG knockout cardiomyocytes ( Figure 8C ; Online Figure XIVA) . Caffeine treatment revealed that the SR calcium load remained normal in SPEG-deficient cardiomyocytes at 4 weeks after induction, but it became significantly lower in SPEG knockout cardiomyocytes than in control cells at 6 weeks after induction ( Figure 8D ). The decay time of the caffeine-induced Ca 2+ peak was normal in SPEG knockout cardiomyocytes ( Figure 8D) -transients but had no effect on Ca 2+ amplitude. Coexpression of SPEG and SERCA2a in HEK293 cells probably did not last long enough to produce a detectable change in Ca 2+ amplitude using our detection method. We further determined spontaneous SR Ca 2+ release and found that frequency of Ca 2+ sparks was unaltered in SPEG-deficient cardiomyocytes at all the 3 time points ( that Ca 2+ release from the SR through RyR2 (ryanodine receptor 2) was normal. The amplitude of Ca 2+ sparks was normal at 4 weeks but displayed a small decrease at 6 weeks in SPEG knockout cardiomyocytes ( Figure 8E and 8F) . Importantly, both FDHM and τ of Ca 2+ sparks were significantly increased in SPEG-deficient cardiomyocytes at all the 3 time points (Figure 8E and 8F; Online Figure XIVB) , further suggesting that SERCA2a activity was decreased. Together, these data demonstrate that SPEG regulates Ca 2+ reuptake into the SR through SERCA2a and that impaired Ca 2+ reuptake preceded cardiac dysfunction and dilation in the heart of the Speg f/f / Myh6-MCM mice after tamoxifen treatment.
Discussion
In this study, we identified SPEG as an important regulator for SERCA2a in the heart and demonstrated that SPEG regulated calcium reuptake into the SR through phosphorylating SERCA2a by its SK2 in cardiomyocytes.
SPEG is a poorly studied protein kinase although it has recently been recognized as an important player in regulating cardiac development and function. 13 It belongs to the MLCK subgroup of CaMK Ser/Thr protein kinase family and has 2 kinase domains in its C-terminal region. 12 The SK1 of SPEG displays more similarity with other kinase members within the MLCK group than does the SK2. 12 Moreover, our data demonstrate that the SK2 of SPEG is responsible for phosphorylation of Thr 484 on SERCA2a, while the SK1 but not the SK2 can phosphorylate JPH2. These results suggest that the SK1 and SK2 of SPEG play distinct roles in the heart. How these 2 kinase domains fulfill such functional diversity remains unclear. One possibility is that the SK1 and SK2 of SPEG have different sequence preferences for their substrate phosphorylation. Identification of the SK1-mediated phosphorylation site(s) on JPH2 may help to determine the sequence preferences for these 2 kinase domains in the future. Another possibility is that the SK1 and SK2 of SPEG may have distinct abilities to interact with their substrates and thereby phosphorylate different proteins. In line with this possibility, the 2 kinase-domains displayed different capacities to interact with their respective substrates JPH2 and SERCA2a. , which raises a further question about whether SUMOylation of SERCA2a also regulates its oligomerization. Previous studies have shown that the ATPase activity of SERCA does not depend on intermolecular interaction between SERCA monomers. 37, 38 However, the ATPase activity is coupled with Ca 2+ -transport within the oligomer of SERCA, and Ca 2+ transport is strongly correlated with the intermolecular interaction of functional SERCA monomers. 11, 39 Our findings further demonstrate the importance of Thr 484 phosphorylation-dependent SERCA2a oligomerization in controlling Ca 2+ -transport, which open new possibilities to modulate SERCA2a activity.
When SERCA2 was deleted in mouse heart using the tamoxifen-inducible Cre, the τ of Ca
2+
-transient was increased by ≈90% to 118% in SERCA2-deficient cardiomyocytes. 40, 41 Impaired SR Ca 2+ reuptake preceded functional alterations of the SERCA2-deficient heart detected via echocardiography. 40 The τ of Ca
-transient was augmented by ≈40% in SPEGdeficient cardiomyocytes in which SERCA2a-Thr 484 phosphorylation was markedly decreased. Furthermore, our data demonstrate that impaired SERCA2a-Thr 484 phosphorylation and delayed Ca 2+ reuptake into the SR also occurred before morphological and functional alterations of the heart of Speg f/f / Myh6-MCM mice, which is at least one of the causes for heart failure in these mice. The different onsets of impaired SR Ca 2+ reuptake and cardiac dysfunction in echocardiographic assessment might reflect the causal relationship between these 2 events in these mouse models. Alternatively, the 2 assays might have different sensitivities. Echocardiographic assessment is performed at the organ level, and might not be sensitive enough to detect subtle changes in cardiac function, if there is any, in the SERCA2 knockout mice or our Speg f/f /Myh6-MCM mice at 4 weeks after tamoxifen induction.
Quick et al 15 recently reported generation of Speg f/f / Myh6-MCM mice using the same embryonic stem cells. 15 In that case, the Speg f/f /Myh6-MCM mice started to die as early as 2 weeks after administration with tamoxifen (dosage unspecified in 15 ) and nearly half of the mice died at 4 weeks post-tamoxifen administration. In our case, the Speg f/f / Myh6-MCM mice displayed no morphological or functional alterations in their heart at 4 weeks post administration with tamoxifen (20 mg/kg per day for 5 consecutive days) and started to die at 13 weeks post-tamoxifen administration. We do not know exactly why the onset and progression of cardiac dysfunction differ in these 2 cases although we suspect that it might be because of different dosage of tamoxifen used for induction. Nevertheless, the different dosage of tamoxifen and kinetics of disease progression together with other experimental conditions might impact on the measurements on calcium reuptake in cardiomyocytes, which differed between the 2 studies. Both studies demonstrate that SR Ca 2+ release through RyR2 was normal in SPEG-deficient cardiomyocytes before heart failure. Quick et al 15 also showed that SR Ca 2+ release was decreased in SPEG-deficient cardiomyocytes at 8 weeks after administration with tamoxifen when the hearts were failing, which was proposed to be secondary in these failing hearts. Our time course studies of Ca 2+ homeostasis in cardiomyocytes consistently revealed delays in SR Ca 2+ reuptake at 4, 6, and 8 weeks after tamoxifen induction, which might lead to a decrease of SR Ca 2+ load and an elevation of Ca 2+ in the cytoplasm. Despite these differences, these 2 studies demonstrate the importance of SPEG in maintaining heart function in adulthood, whose downregulation is associated with cardiac dysfunction in certain diseases.
In summary, we show that the SK1 and SK2 of SPEG may play distinct roles in the heart. The SK2 of SPEG regulates calcium reuptake into the SR through interaction and phosphorylation of SERCA2a in cardiomyocytes. SPEG may serve as a new target to modulate SERCA2a activation for treatment of heart diseases with impaired calcium homeostasis.
